Is It Too Late to Buy iBio Stock?

Zhiyuan Sun, The Motley Fool
·3-min read
Is It Too Late to Buy iBio Stock?
Is It Too Late to Buy iBio Stock?

Stocks of coronavirus vaccine developers garnered investors' attention due to their potential to decisively end the COVID-19 pandemic and allow economies to return to normal via mass immunization. Right now, there are nearly 50 experimental SARS-CoV-2 vaccines in clinical trials and 89 vaccine candidates still in preclinical studies. The COVID-19 vaccine race is coming to an end, as the U.S. Food and Drug Administration (FDA) may issue emergency use authorization to one or more promising late-stage candidates as early as November.